COVID vaccine 90 percent effective in trials

A COVID-19 vaccine being developed by Pfizer and BioNTech is 90% effective at preventing coronavirus in clinical trials. Canada has a deal to buy 20 million doses of that vaccine, and the Prime Minister says we could start deploying them in the first